Chapter 17 : Suppression of Innate Immunity by Orthomyxoviruses

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Suppression of Innate Immunity by Orthomyxoviruses, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815561/9781555814366_Chap17-1.gif /docserver/preview/fulltext/10.1128/9781555815561/9781555814366_Chap17-2.gif


This chapter discusses how influenza virus infection triggers the production of type I interferon (IFNs), the signaling cascades that the cytokines stimulate to establish a protective antiviral response, and the mechanisms that orthomyxoviruses employ to circumvent the host's innate immunity. Orthomyxoviruses employ several strategies to circumvent the host’s innate and adaptive immune responses; the effectiveness by which the viruses apply the strategies contributes to the clinical outcome of virus infections. For influenza A viruses, the viral hemagglutinin and neuraminidase glycoproteins substantially contribute to the pathogenesis of influenza virus infections. An important consideration in the induction of IFN by influenza virus relates to the actual nature of the viral inducer recognized by the cellular sensors. IFN-inducible Mx homologues belong to the dynamin-like family of GTPases that are normally associated with intracellular vesicle trafficking and organelle homeostasis. Promyelocytic leukemia (PML) protein (also known as TRIM19) is an additional IFN-inducible protein that accumulates within nuclear structures that have been referred to as nuclear dot 10 (ND10) or nuclear bodies. The studies discussed in the chapter have concisely described the mechanisms by which, in the absence of the nonstructural protein 1 (NS1), the host detects virus replication, stimulates expression of the IFN-β gene and IFN-stimulated genes (ISGs), and establishes an antiviral state that controls replication of and pathogenicity resulting from infection by orthomyxoviruses.

Citation: Albrecht R, García-Sastre A. 2009. Suppression of Innate Immunity by Orthomyxoviruses, p 267-286. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch17
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Regulation of innate and adaptive immune responses by the influenza A virus NS1 protein. Mutational analyses of the influenza A virus NS1 protein have identified several domains that control its intracellular localization or are essential for its regulation of general gene expression and antiviral immunity. The diverse cellular processes that are regulated by the NS1 protein and the molecules targeted within each process are indicated. The schematic depicts a hypothetical NS1 protein of 230 amino acids. Amino acid positions are identified for the indicated functional domains.

Citation: Albrecht R, García-Sastre A. 2009. Suppression of Innate Immunity by Orthomyxoviruses, p 267-286. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch17
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Regulation of IFN-β and IFN-mediated gene induction during influenza A virus infection. The influenza A virus NS1 protein utilizes several strategies to regulate the induction of type I IFNs, including (i) binding to and sequestration of dsRNA and ssRNA from the cellular sensor, RIG-I; (ii) interaction with RIG-I; and (iii) binding to components involved in mRNA processing, export, and translation. As a consequence of the first two strategies, the NS1 protein blocks the activation of the transcription factors IRF3, NF-κB, and ATF-2/c-Jun, thus preventing the formation of the IFN-β enhanceosome. The third strategy employed by the NS1 protein coupled with the cap-snatching function of the viral polymerase complex contributes to the general inhibition of IFN-β and IFN-induced gene expression.

Citation: Albrecht R, García-Sastre A. 2009. Suppression of Innate Immunity by Orthomyxoviruses, p 267-286. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch17
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Accola, M. A.,, B. Huang,, A. Al Masri, and, M. A. McNiven. 2002. The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum. J. Biol. Chem. 277: 2182921835.
2. Alonso-Caplen, F. V.,, M. E. Nemeroff,, Y. Qiu, and, R. M. Krug. 1992. Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. Genes Dev. 6: 255267.
3. Aragon, T.,, S. de la Luna,, I. Novoa,, L. Carrasco,, J. Ortin, and, A. Nieto. 2000. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol. Cell. Biol. 20: 62596268.
4. Arguello, M. D., and, J. Hiscott. 2007. Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates. Cell Host Microbe 2: 367369.
5. Baez, M.,, J. J. Zazra,, R. M. Elliott,, J. F. Young, and, P. Palese. 1981. Nucleotide sequence of the influenza A/duck/Alberta/60/76 virus NS RNA: conservation of the NS1/NS2 overlapping gene structure in a divergent influenza virus RNA segment. Virology 113: 397402.
6. Balachandran, S.,, P. C. Roberts,, L. E. Brown,, H. Truong,, A. K. Pattnaik,, D. R. Archer, and, G. N. Barber. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13: 129141.
7. Baskin, C. R.,, H. Bielefeldt-Ohmann,, A. Garcia-Sastre,, T. M. Tumpey,, N. Van Hoeven,, V. S. Carter,, M. J. Thomas,, S. Proll,, A. Solorzano,, R. Billharz,, J. L. Fornek,, S. Thomas,, C. H. Chen,, E. A. Clark,, K. Murali-Krishna, and, M. G. Katze. 2007. Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus. J. Virol. 81: 1181711827.
8. Basler, C. F. 2007. Influenza viruses: basic biology and potential drug targets. Infect. Disord. Drug Targets 7: 282293.
9. Basler, C. F.,, A. H. Reid,, J. K. Dybing,, T. A. Janczewski,, T. G. Fanning,, H. Zheng,, M. Salvatore,, M. L. Perdue,, D. E. Swayne,, A. Garcia-Sastre,, P. Palese, and, J. K. Taubenberger. 2001. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS)segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl. Acad. Sci. USA 98: 27462751.
10. Baumgarth, N., and, A. Kelso. 1996. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J. Virol. 70: 44114418.
11. Beaton, A. R., and, R. M. Krug. 1981. Selected host cell capped RNA fragments prime influenza viral RNA transcription in vivo. Nucleic Acids Res. 9: 44234436.
12. Bergmann, M.,, A. Garcia-Sastre,, E. Carnero,, H. Pehamberger,, K. Wolff,, P. Palese, and, T. Muster. 2000. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74: 62036206.
13. Bergmann, M.,, I. Romirer,, M. Sachet,, R. Fleischhacker,, A. Garcia-Sastre,, P. Palese,, K. Wolff,, H. Pehamberger,, R. Jakesz, and, T. Muster. 2001. A genetically engineered influenza A virus with ras-dependent oncolytic properties. Cancer Res. 61: 81888193.
14. Bornholdt, Z. A., and, B. V. Prasad. 2006. X-ray structure of influenza virus NS1 effector domain. Nat. Struct. Mol. Biol. 13: 559560.
15. Bot, A.,, S. Bot, and, C. A. Bona. 1998. Protective role of gamma interferon during the recall response to influenza virus. J. Virol. 72: 66376645.
16. Burgui, I.,, T. Aragon,, J. Ortin, and, A. Nieto. 2003. PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J. Gen. Virol. 84: 32633274.
17. Catic, A.,, E. Fiebiger,, G. A. Korbel,, D. Blom,, P. J. Galardy, and, H. L. Ploegh. 2007. Screen for ISG15-crossreactive deubiquitinases. PLoS ONE 2: e679.
18. Chariot, A.,, A. Leonardi,, J. Muller,, M. Bonif,, K. Brown, and, U. Siebenlist. 2002. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J. Biol. Chem. 277: 3702937036.
19. Chelbi-Alix, M. K.,, L. Pelicano,, F. Quignon,, M. H. Koken,, L. Venturini,, M. Stadler,, J. Pavlovic,, L. Degos, and, H. de The. 1995. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9: 20272033.
20. Chelbi-Alix, M. K.,, F. Quignon,, L. Pelicano,, M. H. Koken, and, H. de The. 1998. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72: 10431051.
21. Chen, G. W.,, S. C. Chang,, C. K. Mok,, Y. L. Lo,, Y. N. Kung,, J. H. Huang,, Y. H. Shih,, J. Y. Wang,, C. Chiang,, C. J. Chen, and, S. R. Shih. 2006. Genomic signatures of human versus avian influenza A viruses. Emerg. Infect. Dis. 12: 13531360.
22. Chen, Z.,, Y. Li, and, R. M. Krug. 1999. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J. 18: 22732283.
23. Cheung, T. K., and, L. L. Poon. 2007. Biology of influenza a virus. Ann. N. Y. Acad. Sci. 1102: 125.
24. Chien, C. Y.,, R. Tejero,, Y. Huang,, D. E. Zimmerman,, C. B. Rios,, R. M. Krug, and, G. T. Montelione. 1997. A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat. Struct. Biol. 4: 891895.
25. Chien, C. Y.,, Y. Xu,, R. Xiao,, J. M. Aramini,, P. V. Sahasrabudhe,, R. M. Krug, and, G. T. Montelione. 2004. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry 43: 19501962.
26. Chu, W. M.,, D. Ostertag,, Z. W. Li,, L. Chang,, Y. Chen,, Y. Hu,, B. Williams,, J. Perrault, and, M. Karin. 1999. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11: 721731.
27. Cole, J. L. 2007. Activation of PKR: an open and shut case? Trends Biochem. Sci. 32: 5762.
28. Crescenzo-Chaigne, B., and, S. van der Werf. 2007. Rescue of influenza C virus from recombinant DNA. J. Virol. 81: 1128211289.
29. Cui, S.,, K. Eisenacher,, A. Kirchhofer,, K. Brzozka,, A. Lammens,, K. Lammens,, T. Fujita,, K. K. Conzelmann,, A. Krug, and, K. P. Hopfner. 2008. The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol. Cell 29: 169179.
30. Dao, C. T., and, D. E. Zhang. 2005. ISG15: a ubiquitin-like enigma. Front. Biosci. 10: 27012722.
31. Dauber, B.,, G. Heins, and, T. Wolff. 2004. The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J. Virol. 78: 18651872.
32. Dauber, B.,, J. Schneider, and, T. Wolff. 2006. Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon. J. Virol. 80: 1166711677.
33. de Jong, M. D.,, C. P. Simmons,, T. T. Thanh,, V. M. Hien,, G. J. Smith,, T. N. Chau,, D. M. Hoang,, N. V. Chau,, T. H. Khanh,, V. C. Dong,, P. T. Qui,, B. V. Cam,, D. Q. Ha,, Y. Guan,, J. S. Peiris,, N. T. Chinh,, T. T. Hien, and, J. Farrar. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12: 12031207.
34. de la Luna, S.,, P. Fortes,, A. Beloso, and, J. Ortin. 1995. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 69: 24272433.
35. Der, S. D.,, A. Zhou,, B. R. Williams, and, R. H. Silverman. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95: 1562315628.
36. de Veer, M. J.,, M. Holko,, M. Frevel,, E. Walker,, S. Der,, J. M. Paranjape,, R. H. Silverman, and, B. R. Williams. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69: 912920.
37. Dever, T. E.,, J. J. Chen,, G. N. Barber,, A. M. Cigan,, L. Feng,, T. F. Donahue,, I. M. London,, M. G. Katze, and, A. G. Hinnebusch. 1993. Mammalian eukaryotic initiation factor 2 alpha kinases functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism of yeast. Proc. Natl. Acad. Sci. USA 90: 46164620.
38. Dittmann, J.,, S. Stertz,, D. Grimm,, J. Steel,, A. Garcia-Sastre,, O. Haller, and, G. Kochs. 2008. Influenza A virus strains differ in sensitivity to the antiviral action of the Mx-GTPase. J. Virol. 82: 36243631.
39. Donelan, N. R.,, C. F. Basler, and, A. Garcia-Sastre. 2003. A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J. Virol. 77: 1325713266.
40. Donelan, N. R.,, B. Dauber,, X. Wang,, C. F. Basler,, T. Wolff, and, A. Garcia-Sastre. 2004. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J. Virol. 78: 1157411582.
41. Dong, B.,, M. Niwa,, P. Walter, and, R. H. Silverman. 2001. Basis for regulated RNA cleavage by functional analysis of RNase L and Ire1p. RNA 7: 361373.
42. Dong, B., and, R. H. Silverman. 1997. A bipartite model of 2–5A-dependent RNase L. J. Biol. Chem. 272: 2223622242.
43. Efferson, C. L.,, N. Tsuda,, K. Kawano,, E. Nistal-Villan,, S. Sellappan,, D. Yu,, J. L. Murray,, A. Garcia-Sastre, and, C. G. Ioannides. 2006. Prostate tumor cells infected with a recombinant influenza virus expressing a truncated NS1 protein activate cytolytic CD8+ cells to recognize noninfected tumor cells. J. Virol. 80: 383394.
44. Ehrhardt, C.,, T. Wolff, and, S. Ludwig. 2007. Activation of phosphatidylinositol 3-kinase signaling by the non-structural NS1 protein is not conserved among type A and B influenza viruses. J. Virol. 81: 1209712100.
45. Enami, K.,, T. A. Sato,, S. Nakada, and, M. Enami. 1994. Influenza virus NS1 protein stimulates translation of the M1 protein. J. Virol. 68: 14321437.
46. Espert, L.,, G. Degols,, C. Gongora,, D. Blondel,, B. R. Williams,, R. H. Silverman, and, N. Mechti. 2003. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA genomic viruses. J. Biol. Chem. 278: 1615116158.
47. Everett, R. D., and, M. K. Chelbi-Alix. 2007. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89: 819830.
48. Falcon, A. M.,, A. Fernandez-Sesma,, Y. Nakaya,, T. M. Moran,, J. Ortin, and, A. Garcia-Sastre. 2005. Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J. Gen. Virol. 86: 28172821.
49. Feigenblum, D., and, R. J. Schneider. 1993. Modification of eukaryotic initiation factor 4F during infection by influenza virus. J. Virol. 67: 30273035.
50. Ferko, B.,, J. Stasakova,, J. Romanova,, C. Kittel,, S. Sereinig,, H. Katinger, and, A. Egorov. 2004. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J. Virol. 78: 1303713045.
51. Fernandez-Sesm, A. 2007. The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. Infect. Disord. Drug Targets 7: 336343.
52. Fernandez-Sesma, A.,, S. Marukian,, B. J. Ebersole,, D. Kaminski,, M. S. Park,, T. Yuen,, S. C. Sealfon,, A. Garcia-Sastre, and, T. M. Moran. 2006. Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80: 62956304.
53. Fitzgerald, K. A.,, S. M. McWhirter,, K. L. Faia,, D. C. Rowe,, E. Latz,, D. T. Golenbock,, A. J. Coyle,, S. M. Liao, and, T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491496.
54. Fodor, E.,, M. Crow,, L. J. Mingay,, T. Deng,, J. Sharps,, P. Fechter, and, G. G. Brownlee. 2002. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J. Virol. 76: 89899001.
55. Fortes, P.,, A. Beloso, and, J. Ortin. 1994. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 13: 704712.
56. Frias-Staheli, N.,, N. V. Giannakopoulos,, M. Kikkert,, S. L. Taylor,, A. Bridgen,, J. Paragas,, J. A. Richt,, R. R. Rowland,, C. S. Schmaljohn,, D. J. Lenschow,, E. J. Snijder,, A. Garcia-Sastre, and, H. W. Virgin IV. 2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2: 404416.
57. Garaigorta, U., and, J. Ortin. 2007. Mutation analysis of a recombinant NS replicon shows that influenza virus NS1 protein blocks the splicing and nucleo-cytoplasmic transport of its own viral mRNA. Nucleic Acids Res. 35: 45734582.
58. Garcia, M. A.,, E. F. Meurs, and, M. Esteban. 2007. The dsRNA protein kinase PKR: virus and cell control. Biochimie 89: 799811.
59. Garcia-Sastre, A.,, R. K. Durbin,, H. Zheng,, P. Palese,, R. Gertner,, D. E. Levy, and, J. E. Durbin. 1998. The role of interferon in influenza virus tissue tropism. J. Virol. 72: 85508558.
60. Garcia-Sastre, A.,, A. Egorov,, D. Matassov,, S. Brandt,, D. E. Levy,, J. E. Durbin,, P. Palese, and, T. Muster. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324330.
61. Gee, P.,, P. K. Chua,, J. Gevorkyan,, K. Klumpp,, I. Najera,, D. C. Swinney, and, J. Deval. 2008. Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity. J. Biol. Chem. 283: 94889496.
62. Gongora, C.,, G. David,, L. Pintard,, C. Tissot,, T. D. Hua,, A. Dejean, and, N. Mechti. 1997. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem. 272: 1945719463.
63. Goodman, A. G.,, J. A. Smith,, S. Balachandran,, O. Perwitasari,, S. C. Proll,, M. J. Thomas,, M. J. Korth,, G. N. Barber,, L. A. Schiff, and, M. G. Katze. 2007. The cellular protein P58 IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J. Virol. 81: 22212230.
64. Greenspan, D.,, P. Palese, and, M. Krystal. 1988. Two nuclear location signals in the influenza virus NS1 non-structural protein. J. Virol. 62: 30203026.
65. Grimm, D.,, P. Staeheli,, M. Hufbauer,, I. Koerner,, L. Martinez-Sobrido,, A. Solorzano,, A. Garcia-Sastre,, O. Haller, and, G. Kochs. 2007. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc. Natl. Acad. Sci. USA 104: 68066811.
66. Grotzinger, T.,, K. Jensen, and, H. Will. 1996. The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem. 271: 2525325260.
67. Guillot, L.,, R. Le Goffic,, S. Bloch,, N. Escriou,, S. Akira,, M. Chignard, and, M. Si-Tahar. 2005. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280: 55715580.
68. Guldner, H. H.,, C. Szostecki,, T. Grotzinger, and, H. Will. 1992. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149: 40674073.
69. Guo, B., and, G. Cheng. 2007. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282: 1181711826.
70. Guo, Z.,, L. M. Chen,, H. Zeng,, J. A. Gomez,, J. Plowden,, T. Fujita,, J. M. Katz,, R. O. Donis, and, S. Sambhara. 2007. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am. J. Respir. Cell Mol. Biol. 36: 263269.
71. Haas, A. L.,, P. Ahrens,, P. M. Bright, and, H. Ankel. 1987. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 262: 1131511323.
72. Hagmaier, K.,, H. R. Gelderblom, and, G. Kochs. 2004. Functional comparison of the two gene products of Thogoto virus segment 6. J. Gen. Virol. 85: 36993708.
73. Hagmaier, K.,, S. Jennings,, J. Buse,, F. Weber, and, G. Kochs. 2003. Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist. J. Virol. 77: 27472752.
74. Haller, O., and, G. Kochs. 2002. Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3: 710717.
75. Haller, O.,, G. Kochs, and, F. Weber. 2007. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev. 18: 425433.
76. Haller, O.,, P. Staeheli, and, G. Kochs. 2007. Interferon-induced Mx proteins in antiviral host defense. Biochimie 89: 812818.
77. Haller, O.,, S. Stertz, and, G. Kochs. 2007. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect. 9: 16361643.
78. Hara, K.,, F. I. Schmidt,, M. Crow, and, G. G. Brownlee. 2006. Amino acid residues in the N-terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding. J. Virol. 80: 77897798.
79. Hatada, E., and, R. Fukuda. 1992. Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73 (Pt. 12): 33253329.
80. Hatada, E.,, S. Saito, and, R. Fukuda. 1999. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. J. Virol. 73: 24252433.
81. Hatada, E.,, T. Takizawa, and, R. Fukuda. 1992. Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro. J. Gen. Virol. 73 (Pt. 1): 1725.
82. Hayman, A.,, S. Comely,, A. Lackenby,, L. C. Hartgroves,, S. Goodbourn,, J. W. McCauley, and, W. S. Barclay. 2007. NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J. Virol. 81: 23182327.
83. Hayman, A.,, S. Comely,, A. Lackenby,, S. Murphy,, J. McCauley,, S. Goodbourn, and, W. Barclay. 2006. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347: 5264.
84. Hemmi, H.,, O. Takeuchi,, S. Sato,, M. Yamamoto,, T. Kaisho,, H. Sanjo,, T. Kawai,, K. Hoshino,, K. Takeda, and, S. Akira. 2004. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199: 16411650.
85. Heuser, M.,, H. van der Kuip,, B. Falini,, C. Peschel,, C. Huber, and, T. Fischer. 1998. Induction of the pro-myelocytic leukaemia gene by type I and type II interferons. Mediators Inflamm. 7: 319325.
86. Holzinger, D.,, C. Jorns,, S. Stertz,, S. Boisson-Dupuis,, R. Thimme,, M. Weidmann,, J. L. Casanova,, O. Haller, and, G. Kochs. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 81: 77767785.
87. Horimoto, T.,, N. Fukuda,, K. Iwatsuki-Horimoto,, Y. Guan,, W. Lim,, M. Peiris,, S. Sugii,, T. Odagiri,, M. Tashiro, and, Y. Kawaoka. 2004. Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003. J. Vet. Med. Sci. 66: 303305.
88. Hornung, V.,, J. Ellegast,, S. Kim,, K. Brzozka,, A. Jung,, H. Kato,, H. Poeck,, S. Akira,, K. K. Conzelmann,, M. Schlee,, S. Endres, and, G. Hartmann. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994997.
89. Isaacs, A., and, D. C. Burke. 1958. Mode of action of interferon. Nature 182: 10731074.
90. Ishihama, A. 1996. A multi-functional enzyme with RNA polymerase and RNase activities: molecular anatomy of influenza virus RNA polymerase. Biochimie 78: 10971102.
91. Jennings, S.,, L. Martinez-Sobrido,, A. Garcia-Sastre,, F. Weber, and, G. Kochs. 2005. Thogoto virus ML protein suppresses IRF3 function. Virology 331: 6372.
92. Jiao, P.,, G. Tian,, Y. Li,, G. Deng,, Y. Jiang,, C. Liu,, W. Liu,, Z. Bu,, Y. Kawaoka, and, H. Chen. 2008. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J. Virol. 82: 11461154.
93. Johnson, N. P., and, J. Mueller. 2002. Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull. Hist. Med. 76: 105115.
94. Joseph, T.,, J. McAuliffe,, B. Lu,, H. Jin,, G. Kemble, and, K. Subbarao. 2007. Evaluation of replication and pathogenicity of avian influenza a H7 subtype viruses in a mouse model. J. Virol. 81: 1055810566.
95. Juang, Y. T.,, W. Lowther,, M. Kellum,, W. C. Au,, R. Lin,, J. Hiscott, and, P. M. Pitha. 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95: 98379842.
96. Kanayama, A.,, R. B. Seth,, L. Sun,, C. K. Ea,, M. Hong,, A. Shaito,, Y. H. Chiu,, L. Deng, and, Z. J. Chen. 2004. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell. 15: 535548.
97. Kash, J. C.,, T. M. Tumpey,, S. C. Proll,, V. Carter,, O. Perwitasari,, M. J. Thomas,, C. F. Basler,, P. Palese,, J. K. Taubenberger,, A. Garcia-Sastre,, D. E. Swayne, and, M. G. Katze. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578581.
98. Kato, H.,, O. Takeuchi,, S. Sato,, M. Yoneyama,, M. Yamamoto,, K. Matsui,, S. Uematsu,, A. Jung,, T. Kawai,, K. J. Ishii,, O. Yamaguchi,, K. Otsu,, T. Tsujimura,, C. S. Koh,, C. Reis e Sousa,, Y. Matsuura,, T. Fujita, and, S. Akira. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101105.
99. Kawai, T.,, K. Takahashi,, S. Sato,, C. Coban,, H. Kumar,, H. Kato,, K. J. Ishii,, O. Takeuchi, and, S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981988.
100. Kim, M. J.,, S. Y. Hwang,, T. Imaizumi, and, J. Y. Yoo. 2008. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 82: 14741483.
101. Kim, T. W.,, K. Staschke,, K. Bulek,, J. Yao,, K. Peters,, K. H. Oh,, Y. Vandenburg,, H. Xiao,, W. Qian,, T. Hamilton,, B. Min,, G. Sen,, R. Gilmour, and, X. Li. 2007. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204: 10251036.
102. Kobasa, D.,, S. M. Jones,, K. Shinya,, J. C. Kash,, J. Copps,, H. Ebihara,, Y. Hatta,, J. H. Kim,, P. Halfmann,, M. Hatta,, F. Feldmann,, J. B. Alimonti,, L. Fernando,, Y. Li,, M. G. Katze,, H. Feldmann, and, Y. Kawaoka. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319323.
103. Kochs, G.,, A. Garcia-Sastre, and, L. Martinez-Sobrido. 2007. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 81: 70117021.
104. Kochs, G.,, I. Koerner,, L. Thiel,, S. Kothlow,, B. Kaspers,, N. Ruggli,, A. Summerfield,, J. Pavlovic,, J. Stech, and, P. Staeheli. 2007. Properties of H7N7 influenza A virus strain SC35M lacking interferon antagonist NS1 in mice and chickens. J. Gen. Virol. 88: 14031409.
105. Kochs, G.,, F. Weber,, S. Gruber,, A. Delvendahl,, C. Leitz, and, O. Haller. 2000. Thogoto virus matrix protein is encoded by a spliced mRNA. J. Virol. 74: 1078510789.
106. Koerner, I.,, G. Kochs,, U. Kalinke,, S. Weiss, and, P. Staeheli. 2007. Protective role of beta interferon in host defense against influenza A virus. J. Virol. 81: 20252030.
107. Koyama, S.,, K. J. Ishii,, H. Kumar,, T. Tanimoto,, C. Coban,, S. Uematsu,, T. Kawai, and, S. Akira. 2007. Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J. Immunol. 179: 47114720.
108. Krug, R. M. 1981. Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr. Top. Microbiol. Immunol. 93: 125149.
109. Leahy, M. B.,, J. T. Dessens, and, P. A. Nuttall. 1997. In vitro polymerase activity of Thogoto virus: evidence for a unique cap-snatching mechanism in a tick-borne orthomyxovirus. J. Virol. 71: 83478351.
110. Lee, T. G.,, N. Tang,, S. Thompson,, J. Miller, and, M. G. Katze. 1994. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol. 14: 23312342.
111. Le Goffic, R.,, V. Balloy,, M. Lagranderie,, L. Alexopoulou,, N. Escriou,, R. Flavell,, M. Chignard, and, M. Si-Tahar. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2: e53.
112. Le Goffic, R.,, J. Pothlichet,, D. Vitour,, T. Fujita,, E. Meurs,, M. Chignard, and, M. Si-Tahar. 2007. Cutting edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178: 33683372.
113. Lenschow, D. J.,, C. Lai,, N. Frias-Staheli,, N. V. Giannakopoulos,, A. Lutz,, T. Wolff,, A. Osiak,, B. Levine,, R. E. Schmidt,, A. Garcia-Sastre,, D. A. Leib,, A. Pekosz,, K. P. Knobeloch,, I. Horak, and, H. W. Virgin IV. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. USA 104: 13711376.
114. Li, M., and, B. Wang. 2007. Homology modeling and examination of the effect of the D92E mutation on the H5N1 nonstructural protein NS1 effector domain. J. Mol. Model. 13: 12371244.
115. Li, M. L.,, P. Rao, and, R. M. Krug. 2001. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J. 20: 20782086.
116. Li, S.,, J. Y. Min,, R. M. Krug, and, G. C. Sen. 2006. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349: 1321.
117. Li, Y.,, Z. Y. Chen,, W. Wang,, C. C. Baker, and, R. M. Krug. 2001. The 3′-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA 7: 920931.
118. Li, Y.,, Y. Yamakita, and, R. M. Krug. 1998. Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc. Natl. Acad. Sci. USA 95: 48644869.
119. Liu, J.,, P. A. Lynch,, C. Y. Chien,, G. T. Montelione,, R. M. Krug, and, H. M. Berman. 1997. Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat. Struct. Biol. 4: 896899.
120. Loeb, K. R., and, A. L. Haas. 1992. The interferoninducible 15-kDa ubiquitin homolog conjugates to intra-cellular proteins. J. Biol. Chem. 267: 78067813.
121. Loo, Y. M.,, J. Fornek,, N. Crochet,, G. Bajwa,, O. Perwitasari,, L. Martinez-Sobrido,, S. Akira,, M. A. Gill,, A. Garcia-Sastre,, M. G. Katze, and, M. Gale, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335345.
122. Lu, G.,, J. T. Reinert,, I. Pitha-Rowe,, A. Okumura,, M. Kellum,, K. P. Knobeloch,, B. Hassel, and, P. M. Pitha. 2006. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell. Mol. Biol. (Noisy-le-grand) 52: 2941.
123. Lu, J.,, E. B. O’Hara,, B. A. Trieselmann,, P. R. Romano, and, T. E. Dever. 1999. The interferon-induced double-stranded RNA-activated protein kinase PKR will phosphorylate serine, threonine, or tyrosine at residue 51 in eukaryotic initiation factor 2alpha. J. Biol. Chem. 274: 3219832203.
124. Lu, Y.,, X. Y. Qian, and, R. M. Krug. 1994. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev. 8: 18171828.
125. Lu, Y.,, M. Wambach,, M. G. Katze, and, R. M. Krug. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214: 222228.
126. Ludwig, S.,, X. Wang,, C. Ehrhardt,, H. Zheng,, N. Donelan,, O. Planz,, S. Pleschka,, A. Garcia-Sastre,, G. Heins, and, T. Wolff. 2002. The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J. Virol. 76: 1116611171.
127. Malakhov, M. P.,, O. A. Malakhova,, K. I. Kim,, K. J. Ritchie, and, D. E. Zhang. 2002. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277: 99769981.
128. Malakhova, O. A.,, K. I. Kim,, J. K. Luo,, W. Zou,, K. G. Kumar,, S. Y. Fuchs,, K. Shuai, and, D. E. Zhang. 2006. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25: 23582367.
129. Malakhova, O. A.,, M. Yan,, M. P. Malakhov,, Y. Yuan,, K. J. Ritchie,, K. I. Kim,, L. F. Peterson,, K. Shuai, and, D. E. Zhang. 2003. Protein ISGylation modulates the JAK-Stat signaling pathway. Genes Dev. 17: 455460.
130. Malathi, K.,, B. Dong,, M. Gale, Jr., and, R. H. Silverman. 2007. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816819.
131. Malathi, K.,, J. M. Paranjape,, E. Bulanova,, M. Shim,, J. M. Guenther-Johnson,, P. W. Faber,, T. E. Eling,, B. R. Williams, and, R. H. Silverman. 2005. A transcriptional signaling pathway in the IFN system mediated by 2′-5′-oligoadenylate activation of RNase L. Proc. Natl. Acad. Sci. USA 102: 1453314538.
132. Marcus, P. I.,, J. M. Rojek, and, M. J. Sekellick. 2005. Interferon induction and/or production and its suppression by influenza A viruses. J. Virol. 79: 28802890.
133. Marion, R. M.,, T. Aragon,, A. Beloso,, A. Nieto, and, J. Ortin. 1997. The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res. 25: 42714277.
134. McBeath, A. J.,, B. Collet,, R. Paley,, S. Duraffour,, V. Aspehaug,, E. Biering,, C. J. Secombes, and, M. Snow. 2006. Identification of an interferon antagonist protein encoded by segment 7 of infectious salmon anaemia virus. Virus Res. 115: 176184.
135. Melen, K.,, L. Kinnunen,, R. Fagerlund,, N. Ikonen,, K. Y. Twu,, R. M. Krug, and, I. Julkunen. 2007. Nuclear and nucleolar targeting of influenza A virus NS1 protein:striking differences between different virus subtypes. J. Virol. 81: 59956006.
136. Mellor, H., and, C. G. Proud. 1991. A synthetic peptide substrate for initiation factor-2 kinases. Biochem. Biophys. Res. Commun. 178: 430437.
137. Melville, M. W.,, W. J. Hansen,, B. C. Freeman,, W. J. Welch, and, M. G. Katze. 1997. The molecular chaperone hsp40 regulates the activity of P58 IPK, the cellular inhibitor of PKR. Proc. Natl. Acad. Sci. USA 94: 97102.
138. Meylan, E.,, J. Curran,, K. Hofmann,, D. Moradpour,, M. Binder,, R. Bartenschlager, and, J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 11671172.
139. Mibayashi, M.,, L. Martinez-Sobrido,, Y. M. Loo,, W. B. Cardenas,, M. Gale, Jr., and, A. Garcia-Sastre. 2007. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 81: 514524.
140. Mikulasova, A.,, E. Vareckova, and, E. Fodor. 2000. Transcription and replication of the influenza A virus genome. Acta Virol. 44: 273282.
141. Min, J. Y., and, R. M. Krug. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc. Natl. Acad. Sci. USA 103: 71007105.
142. Muster, T.,, J. Rajtarova,, M. Sachet,, H. Unger,, R. Fleischhacker,, I. Romirer,, A. Grassauer,, A. Url,, A. Garcia-Sastre,, K. Wolff,, H. Pehamberger, and, M. Bergmann. 2004. Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants. Int. J. Cancer 110: 1521.
143. Nemeroff, M. E.,, S. M. Barabino,, Y. Li,, W. Keller, and, R. M. Krug. 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′ end formation of cellular pre-mRNAs. Mol. Cell 1: 9911000.
144. Nguyen, H. H.,, F. W. van Ginkel,, H. L. Vu,, M. J. Novak,, J. R. McGhee, and, J. Mestecky. 2000. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice. J. Virol. 74: 54955501.
145. Nguyen, L. H.,, L. Espert,, N. Mechti, and, D. M. Wilson, III. 2001. The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry 40: 71747179.
146. Noah, D. L.,, K. Y. Twu, and, R. M. Krug. 2003. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307: 386395.
147. Norton, G. P.,, T. Tanaka,, K. Tobita,, S. Nakada,, D. A. Buonagurio,, D. Greenspan,, M. Krystal, and, P. Palese. 1987. Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypep-tides. Virology 156: 204213.
148. Obenauer, J. C.,, J. Denson,, P. K. Mehta,, X. Su,, S. Mukatira,, D. B. Finkelstein,, X. Xu,, J. Wang,, J. Ma,, Y. Fan,, K. M. Rakestraw,, R. G. Webster,, E. Hoffmann,, S. Krauss,, J. Zheng,, Z. Zhang, and, C. W. Naeve. 2006. Large-scale sequence analysis of avian influenza isolates. Science 311: 15761580.
149. Oganesyan, G.,, S. K. Saha,, B. Guo,, J. Q. He,, A. Shahangian,, B. Zarnegar,, A. Perry, and, G. Cheng. 2006. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439: 208211.
150. Okumura, A.,, G. Lu,, I. Pitha-Rowe, and, P. M. Pitha. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. USA 103: 14401445.
151. Opitz, B.,, A. Rejaibi,, B. Dauber,, J. Eckhard,, M. Vinzing,, B. Schmeck,, S. Hippenstiel,, N. Suttorp, and, T. Wolff. 2007. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell. Microbiol. 9: 930938.
152. Osterhaus, A. D.,, G. F. Rimmelzwaan,, B. E. Martina,, T. M. Bestebroer, and, R. A. Fouchier. 2000. Influenza B virus in seals. Science 288: 10511053.
153. Ozaki, H., and, H. Kida. 2007. Extensive accumulation of influenza virus NS1 protein in the nuclei causes effective viral growth in vero cells. Microbiol. Immunol. 51: 577580.
154. Palese, P., and, M. L. Shaw. 2006. Orthomyxoviridae: the Viruses and Their Replication, 5th ed., vol. 1. Lippincott, Williams & Wilkins, Philadelphia, PA.
155. Panne, D.,, T. Maniatis, and, S. C. Harrison. 2007. An atomic model of the interferon-beta enhanceosome. Cell 129: 11111123.
156. Peiris, J. S.,, M. D. de Jong, and, Y. Guan. 2007. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev. 20: 243267.
157. Perry, A. K.,, E. K. Chow,, J. B. Goodnough,, W. C. Yeh, and, G. Cheng. 2004. Differential requirement for TANK-binding kinase-1 in type I interferon responses to Toll-like receptor activation and viral infection. J. Exp. Med. 199: 16511658.
158. Pichlmair, A.,, J. Buse,, S. Jennings,, O. Haller,, G. Kochs, and, P. Staeheli. 2004. Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice. J. Virol. 78: 1142211424.
159. Pichlmair, A.,, O. Schulz,, C. P. Tan,, T. I. Naslund,, P. Liljestrom,, F. Weber, and, C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 9971001.
160. Plotch, S. J.,, M. Bouloy,, I. Ulmanen, and, R. M. Krug. 1981. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell 23: 847858.
161. Price, G. E.,, A. Gaszewska-Mastarlarz, and, D. Moskophidis. 2000. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J. Virol. 74: 39964003.
162. Qian, X. Y.,, C. Y. Chien,, Y. Lu,, G. T. Montelione, and, R. M. Krug. 1995. An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1: 948956.
163. Qiu, Y., and, R. M. Krug. 1994. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68: 24252432.
164. Qiu, Y.,, M. Nemeroff, and, R. M. Krug. 1995. The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA 1: 304316.
165. Quinlivan, M.,, D. Zamarin,, A. Garcia-Sastre,, A. Cullinane,, T. Chambers, and, P. Palese. 2005. Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79: 84318439.
166. Rebouillat, D., and, A. G. Hovanessian. 1999. The human 2′,5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J. Interferon Cytokine Res. 19: 295308.
167. Saha, S. K.,, E. M. Pietras,, J. Q. He,, J. R. Kang,, S. Y. Liu,, G. Oganesyan,, A. Shahangian,, B. Zarnegar,, T. L. Shiba,, Y. Wang, and, G. Cheng. 2006. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25: 32573263.
168. Salomon, R.,, E. Hoffmann, and, R. G. Webster. 2007. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl. Acad. Sci. USA 104: 1247912481.
169. Salomon, R.,, P. Staeheli,, G. Kochs,, H. L. Yen,, J. Franks,, J. E. Rehg,, R. G. Webster, and, E. Hoffmann. 2007. Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle 6: 24172421.
170. Salvatore, M.,, C. F. Basler,, J. P. Parisien,, C. M. Horvath,, S. Bourmakina,, H. Zheng,, T. Muster,, P. Palese, and, A. Garcia-Sastre. 2002. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 76: 12061212.
171. Sandrock, M.,, M. Frese,, O. Haller, and, G. Kochs. 2001. Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses. J. Interferon Cytokine Res. 21: 663668.
172. Sato, M.,, N. Tanaka,, N. Hata,, E. Oda, and, T. Taniguchi. 1998. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett. 425: 112116.
173. Sato, Y.,, K. Yoshioka,, C. Suzuki,, S. Awashima,, Y. Hosaka,, J. Yewdell, and, K. Kuroda. 2003. Localization of influenza virus proteins to nuclear dot 10 structures in influenza virus-infected cells. Virology 310: 2940.
174. Satterly, N.,, P. L. Tsai,, J. van Deursen,, D. R. Nussenzveig,, Y. Wang,, P. A. Faria,, A. Levay,, D. E. Levy, and, B. M. Fontoura. 2007. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. USA 104: 18531858.
175. Seo, S. H.,, E. Hoffmann, and, R. G. Webster. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8: 950954.
176. Seth, R. B.,, L. Sun,, C. K. Ea, and, Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NFkappaB and IRF 3. Cell 122: 669682.
177. Sharma, S.,, B. R. tenOever,, N. Grandvaux,, G. P. Zhou,, R. Lin, and, J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300: 11481151.
178. Smith, E. J.,, I. Marie,, A. Prakash,, A. Garcia-Sastre, and, D. E. Levy. 2001. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by vaccinia virus E3L protein. J. Biol. Chem. 276: 89518957.
179. Solorzano, A.,, R. J. Webby,, K. M. Lager,, B. H. Janke,, A. Garcia-Sastre, and, J. A. Richt. 2005. Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J. Virol. 79: 75357543.
180. Stadler, M.,, M. K. Chelbi-Alix,, M. H. Koken,, L. Venturini,, C. Lee,, A. Saib,, F. Quignon,, L. Pelicano,, M. C. Guillemin,, C. Schindler, and, H. de The. 1995. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11: 25652573.
181. Stertz, S.,, J. Dittmann,, J. C. Blanco,, L. M. Pletneva,, O. Haller, and, G. Kochs. 2007. The antiviral potential of interferon-induced cotton rat Mx proteins against orthomyxovirus (influenza), rhabdovirus, and bunyavirus. J. Interferon Cytokine Res. 27: 847855.
182. Stertz, S.,, M. Reichelt,, J. Krijnse-Locker,, J. Mackenzie,, J. C. Simpson,, O. Haller, and, G. Kochs. 2006. Interferon-induced, antiviral human MxA protein localizes to a distinct subcompartment of the smooth endoplasmic reticulum. J. Interferon Cytokine Res. 26: 650660.
183. Szretter, K. J.,, S. Gangappa,, X. Lu,, C. Smith,, W. J. Shieh,, S. R. Zaki,, S. Sambhara,, T. M. Tumpey, and, J. M. Katz. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 81: 27362744.
184. Takahasi, K.,, M. Yoneyama,, T. Nishihori,, R. Hirai,, H. Kumeta,, R. Narita,, M. Gale, Jr.,, F. Inagaki, and, T. Fujita. 2008. Nonself RNA-sensing mechanism of RIGI helicase and activation of antiviral immune responses. Mol. Cell 29: 428440.
185. Talon, J.,, C. M. Horvath,, R. Polley,, C. F. Basler,, T. Muster,, P. Palese, and, A. Garcia-Sastre. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 74: 79897996.
186. Tan, S. L., and, M. G. Katze. 1998. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J. Interferon Cytokine Res. 18: 757766.
187. Thimme, R.,, M. Frese,, G. Kochs, and, O. Haller. 1995. Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. Virology 211: 296301.
188. Treanor, J. J.,, M. H. Snyder,, W. T. London, and, B. R. Murphy. 1989. The B allele of the NS gene of avian influenza viruses, but not the A allele, attenuates a human influenza A virus for squirrel monkeys. Virology 171: 19.
189. Tumpey, T. M.,, K. J. Szretter,, N. Van Hoeven,, J. M. Katz,, G. Kochs,, O. Haller,, A. Garcia-Sastre, and, P. Staeheli. 2007. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J. Virol. 81: 1081810821.
190. Turan, K.,, M. Mibayashi,, K. Sugiyama,, S. Saito,, A. Numajiri, and, K. Nagata. 2004. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res. 32: 643652.
191. Twu, K. Y.,, R. L. Kuo,, J. Marklund, and, R. M. Krug. 2007. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J. Virol. 81: 81128121.
192. Vincent, A. L.,, W. Ma,, K. M. Lager,, B. H. Janke,, R. J. Webby,, A. Garcia-Sastre, and, J. A. Richt. 2007. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 25: 79998009.
193. Wang, W., and, R. M. Krug. 1996. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses. Virology 223: 4150.
194. Wang, W., and, R. M. Krug. 1998. U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition of AT-AC splicing by the influenza virus NS1 protein. RNA 4: 5564.
195. Wang, W.,, K. Riedel,, P. Lynch,, C. Y. Chien,, G. T. Montelione, and, R. M. Krug. 1999. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5: 195205.
196. Wang, X.,, C. F. Basler,, B. R. Williams,, R. H. Silverman,, P. Palese, and, A. Garcia-Sastre. 2002. Functional replacement of the carboxy-terminal two-thirds of the influenza A virus NS1 protein with short heterologous dimerization domains. J. Virol. 76: 1295112962.
197. Wang, X.,, E. R. Hinson, and, P. Cresswell. 2007. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2: 96105.
198. Wang, X.,, M. Li,, H. Zheng,, T. Muster,, P. Palese,, A. A. Beg, and, A. Garcia-Sastre. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 74: 1156611573.
199. Wathelet, M. G.,, C. H. Lin,, B. S. Parekh,, L. V. Ronco,, P. M. Howley, and, T. Maniatis. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1: 507518.
200. Weaver, B. K.,, K. P. Kumar, and, N. C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/ p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18: 13591368.
201. Weber, F.,, O. Haller, and, G. Kochs. 1996. Nucleoprotein viral RNA and mRNA of Thogoto virus: a novel “cap-stealing” mechanism in tick-borne orthomyxoviruses? J. Virol. 70: 83618367.
202. Weber, F.,, V. Wagner,, S. B. Rasmussen,, R. Hartmann, and, S. R. Paludan. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80: 50595064.
203. Wolff, T.,, R. E. O’Neill, and, P. Palese. 1998. NS1-binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J. Virol. 72: 71707180.
204. Xu, L. G.,, Y. Y. Wang,, K. J. Han,, L. Y. Li,, Z. Zhai, and, H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19: 727740.
205. Yang, Y. L.,, L. F. Reis,, J. Pavlovic,, A. Aguzzi,, R. Schafer,, A. Kumar,, B. R. Williams,, M. Aguet, and, C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14: 60956106.
206. Yin, C.,, J. A. Khan,, G. V. Swapna,, A. Ertekin,, R. M. Krug,, L. Tong, and, G. T. Montelione. 2007. Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. J. Biol. Chem. 282: 2058420592.
207. Yoneyama, M.,, W. Suhara,, Y. Fukuhara,, M. Fukuda,, E. Nishida, and, T. Fujita. 1998. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17: 10871095.
208. Yuan, W.,, J. M. Aramini,, G. T. Montelione, and, R. M. Krug. 2002. Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: a protein-protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus. Virology 304: 291301.
209. Yuan, W., and, R. M. Krug. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20: 362371.
210. Zhao, C.,, C. Denison,, J. M. Huibregtse,, S. Gygi, and, R. M. Krug. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. USA 102: 1020010205.
211. Zhao, T.,, L. Yang,, Q. Sun,, M. Arguello,, D. W. Ballard,, J. Hiscott, and, R. Lin. 2007. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 8: 592600.
212. Zhou, A.,, J. Paranjape,, T. L. Brown,, H. Nie,, S. Naik,, B. Dong,, A. Chang,, B. Trapp,, R. Fairchild,, C. Colmenares, and, R. H. Silverman. 1997. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16: 63556363.
213. Zurcher, T.,, R. M. Marion, and, J. Ortin. 2000. Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity. J. Virol. 74: 87818784.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error